LENAKAST (LENALIDOMIDE)

LENAKAST (LENALIDOMIDE) – is prescribed in capsules for oral administration, usually a course of 21 days, followed by a 7-day break. Thus, a 28-day treatment cycle is formed. The appointment and duration of treatment is determined by the doctor. The optimal dose, the duration of treatment largely depends on the clinical picture of the disease, as well as on the individual characteristics of the patient.

However, for comparison, in leading clinical trials, a dose of 25 mg daily was used for 21 days, with a break of 7 days. Patients were treated until the progression of myeloma began. 2,3 Treatment of myeloma in most cases becomes more effective if two or more drugs are used with different, but synergistic (reinforcing) mechanisms of action. In the treatment of myeloma, lenalidomide is used in combination with the steroid hormone dexamethasone.

If treatment is ineffective, it may be necessary to increase the dose or add another drug to the regimen. When the maximum effect is achieved, the dose of drugs can be reduced. If the disease progresses, despite an increase in dosages or the introduction of additional drugs, then the doctor, as a rule, changes therapy and switches to alternative regimens to lay down